Core Insights - SeaStar Medical Holding Corporation announced positive early post-approval clinical experience for QUELIMMUNE therapy, showing strong survival rates in pediatric patients with Acute Kidney Injury (AKI) and sepsis [1][2][3] Group 1: Clinical Data and Outcomes - The SAVE Registry reported a 76% survival rate at Day 28 and Day 60, and a 71% survival rate at Day 90 for pediatric patients treated with QUELIMMUNE therapy [3] - No device-related adverse events or infections were observed in the first 21 patients, indicating a favorable safety profile [3][5] - Among patients treated with QUELIMMUNE and requiring extracorporeal membrane oxygenation (ECMO), a 60% survival rate was noted at Day 90 [4] Group 2: Regulatory and Adoption Insights - The FDA initially required 300 patients for the SAVE Registry but reduced the target to 50 after reviewing data from the first 21 patients [5] - QUELIMMUNE therapy has been adopted by several top-rated children's medical centers across the United States [6] Group 3: Company Background and Product Information - SeaStar Medical focuses on transforming treatments for critically ill patients facing organ failure, with QUELIMMUNE being its first commercial product approved in 2024 [12][13] - The Selective Cytopheretic Device (SCD) therapy aims to neutralize overactive immune cells and mitigate destructive hyperinflammation, with potential applications in various acute and chronic conditions [11]

Core Viewpoint - Falcon Energy Materials plc has announced a non-brokered private placement to raise gross proceeds of C$25,000,000, indicating strong shareholder confidence and support for the company's strategic direction and future projects [1][3]. Private Placement Details - The company will issue up to 41,666,667 units at a price of C$0.60 per unit, with each unit consisting of one ordinary share and one non-transferable share purchase warrant [2]. - Each warrant allows the holder to purchase an additional share at a price of C$0.75 for a period of 36 months from the closing date [2]. - Proceeds from the private placement will be allocated to the development of the Morocco Anode Plant and general working capital [3]. Shareholder Support - The private placement is backed by the company's largest shareholders, reflecting confidence in Falcon's strategy and long-term prospects [3]. - The company is also welcoming new high-profile shareholders with strong business relationships globally, which may enhance its market position [3]. Regulatory and Insider Participation - The private placement is subject to standard regulatory approvals, including those from the TSX Venture Exchange [3]. - Insider participation in the private placement is expected, although the extent has not yet been determined [4]. Company Overview - Falcon Energy Materials aims to be a leading provider of natural Coated Spheronized Purified Graphite, essential for energy storage solutions [6]. - The company is developing a state-of-the-art production facility in Morocco with a capacity of 25,000 tons per annum [6]. - Falcon has strategic partnerships with leading Chinese technology firms and Tier One Moroccan partners, enhancing its technological capabilities and access to quality raw materials [7].

The Board of Directors of Kvika banki hf. is set to approve the financial statements of the Group for the year 2025 at a board meeting on Wednesday 11 February. The financial statements will subsequently be published after the domestic market has closed. A meeting to present the results to shareholders and market participants will be held the next day, at 08:30 on Thursday 12 February, at the bank's headquarters on the 9th floor at Katrínartún 2, where Ármann Þorvaldsson, CEO of Kvika, and Eiríkur Magnús Je ...

Tesla Stock Is Down. What's Next for Shares. - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# Tesla Stock Edges Up. A Bottom Might Be In.By [Al Root]ShareResize---ReprintsIn this article[TSLA][SPX][DJIA]Tesla stock has been frozen since it r ...

Vancouver, Canada, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced additional positive safety topline results from the second cohort of its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, the Company’s proprietary non-hallucinogenic MEAI-ba ...

CNA Financial (CNA) came out with quarterly earnings of $1.16 per share, missing the Zacks Consensus Estimate of $1.2 per share. This compares to earnings of $1.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -3.33%. A quarter ago, it was expected that this insurance holding company would post earnings of $1.25 per share when it actually produced earnings of $1.5, delivering a surprise of +20%.Over the last four quarters, t ...

PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Cygnet.One today announced its approval as an AWS Amazon ECS Service Delivery Partner. The designation recognizes Cygnet.One’s validated expertise in container orchestration and cloud-native application delivery using Amazon Elastic Container Service on AWS. AWS Recognizes Cygnet.One Under the Amazon ECS Service Delivery Program AWS has officially approved Cygnet.One as part of the Amazon ECS Service Delivery Program, which identifies partners with proven t ...

At Trade With Beta , we also pay close attention to closed-end funds and are always keeping an eye on them for directional and arbitrage opportunities created by market price deviations. As you can guess, timing is crucial in these kinds of trades; therefore, you are welcome to join us for early access and the discussions accompanying these kinds of trades.In the following lines, you will find detailed information about most of our readers' favorite fund and its holdings. We talk about Virtus InfraCap U.S. ...

New management, and revenue producing acquisitions. DALLAS, TEXAS / ACCESS Newswire / February 9, 2026 / Auri Inc, (OTCID:AURI) - a cutting-edge driven incubating holding company continues to advance its business operations adding new revenues. ...

TORONTO, ON / ACCESS Newswire / February 9, 2026 / White Gold Corp. (TSX.V:WGO) (OTCQX:WHGOF)(FRA:29W) (the "Company") is pleased to announce the appointment of Donovan Pollitt, P.Eng., CFA, as a Strategic Advisor and Consultant. Mr. Pollitt is a highly respected and seasoned mining executive with over 20 years of experience in mining operations, executive management and capital markets activities. Donovan currently serves as President of Pollitt Mining Inc., a management consultancy firm providing a range ...